Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infection of brain-derived cells with the human immunodeficiency virus.

Literature DB >> 3644020

Infection of brain-derived cells with the human immunodeficiency virus.

F Chiodi, S Fuerstenberg, M Gidlund, B Asjö, E M Fenyö.

Abstract

A malignant glioma cell line was infected with the human T-lymphotropic virus type IIIB isolate of the human immunodeficiency virus. Infection appeared to be latent rather than productive. Through contact with monocytic or lymphoid cells, the virus present in the glioma cells could be transmitted and gave rise to a fully productive infection.

Entities: Disease Species

Mesh：

Year: 1987 PMID： 3644020 PMCID： PMC254087 DOI： 10.1128/JVI.61.4.1244-1247.1987

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

19 in total

1. Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies.

Authors: G Pétursson; N Nathanson; G Georgsson; H Panitch; P A Pálsson
Journal: Lab Invest Date: 1976-10 Impact factor: 5.662

Review 2. Experimental visna in Icelandic sheep: the prototype lentiviral infection.

Authors: N Nathanson; G Georgsson; P A Pálsson; J A Najjar; R Lutley; G Pétursson
Journal: Rev Infect Dis Date: 1985 Jan-Feb

3. Human immunodeficiency viruses.

Authors: J Coffin; A Haase; J A Levy; L Montagnier; S Oroszlan; N Teich; H Temin; K Toyoshima; H Varmus; P Vogt
Journal: Science Date: 1986-05-09 Impact factor: 47.728

4. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.

Authors: B Asjö; L Morfeldt-Månson; J Albert; G Biberfeld; A Karlsson; K Lidman; E M Fenyö
Journal: Lancet Date: 1986-09-20 Impact factor: 79.321

5. The AIDS dementia complex: I. Clinical features.

Authors: B A Navia; B D Jordan; R W Price
Journal: Ann Neurol Date: 1986-06 Impact factor: 10.422

6. Determinants for the establishment of permanent tissue culture lines from human gliomas.

Authors: B Westermark; J Pontén; R Hugosson
Journal: Acta Pathol Microbiol Scand A Date: 1973-11

7. Long term culture of normal and neoplastic human glia.

Authors: J Pontén; E H Macintyre
Journal: Acta Pathol Microbiol Scand Date: 1968

Review 8. The slow infection caused by visna virus.

Authors: A T Haase
Journal: Curr Top Microbiol Immunol Date: 1975 Impact factor: 4.291

9. Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors: C Sundström; K Nilsson
Journal: Int J Cancer Date: 1976-05-15 Impact factor: 7.396

10. The AIDS dementia complex: II. Neuropathology.

Authors: B A Navia; E S Cho; C K Petito; R W Price
Journal: Ann Neurol Date: 1986-06 Impact factor: 10.422

58 in total

Review 1. Neurotoxicity of macrophages infected by HIV1.

Authors: M Tardieu; C Hery; S Peudenier
Journal: Cell Biol Toxicol Date: 1992 Jul-Sep Impact factor: 6.691

2. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus.

Authors: C Cheng-Mayer; C Weiss; D Seto; J A Levy
Journal: Proc Natl Acad Sci U S A Date: 1989-11 Impact factor: 11.205

3. The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion.

Authors: J D Reeves; T F Schulz
Journal: J Virol Date: 1997-02 Impact factor: 5.103

4. Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent.

Authors: Ashok Chauhan
Journal: Microbes Infect Date: 2015-06-02 Impact factor: 2.700

5. Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV.

Authors: S Dewhurst; K Sakai; J Bresser; M Stevenson; M J Evinger-Hodges; D J Volsky
Journal: J Virol Date: 1987-12 Impact factor: 5.103

6. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.

Authors: J P Taylor; R J Pomerantz; G V Raj; F Kashanchi; J N Brady; S Amini; K Khalili
Journal: J Virol Date: 1994-06 Impact factor: 5.103

Review 7. Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors: Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal: Curr HIV Res Date: 2008-09 Impact factor: 1.581

8. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1.

Authors: J E Merrill; Y Koyanagi; J Zack; L Thomas; F Martin; I S Chen
Journal: J Virol Date: 1992-04 Impact factor: 5.103

9. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.

Authors: B Chesebro; J Nishio; S Perryman; A Cann; W O'Brien; I S Chen; K Wehrly
Journal: J Virol Date: 1991-11 Impact factor: 5.103

10. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta.

Authors: C Tornatore; A Nath; K Amemiya; E O Major
Journal: J Virol Date: 1991-11 Impact factor: 5.103